Potter DE - Search Results

1

Muscle-specific effects of hindlimb suspension and clenbuterol in mature male rats.

Wineski LE, von Deutsch DA, Abukhalaf IK, Pitts SA, Potter DE, Paulsen DF. Wineski LE, et al. Among authors: potter de. Cells Tissues Organs. 2002;171(2-3):188-98. doi: 10.1159/000063712. Cells Tissues Organs. 2002. PMID: 12097841

2

Effect of hindlimb suspension and clenbuterol treatment on polyamine levels in skeletal muscle.

Abukhalaf IK, von Deutsch DA, Wineski LE, Silvestrov NA, Abera SA, Sahlu SW, Potter DE. Abukhalaf IK, et al. Among authors: potter de. Pharmacology. 2002 Jul;65(3):145-54. doi: 10.1159/000058041. Pharmacology. 2002. PMID: 12037378

3

Changes in muscle proteins and spermidine content in response to unloading and clenbuterol treatment.

von Deutsch DA, Abukhalaf IK, Wineski LE, Silvestrov NA, Bayorh MA, Potter DE. von Deutsch DA, et al. Among authors: potter de. Can J Physiol Pharmacol. 2003 Jan;81(1):28-39. doi: 10.1139/y02-169. Can J Physiol Pharmacol. 2003. PMID: 12665255

4

Comparative analytical quantitation of clenbuterol in biological matrices using GC-MS and EIA.

Abukhalaf IK, von Deutsch DA, Parks BA, Wineski L, Paulsen D, Aboul-Enein HY, Potter DE. Abukhalaf IK, et al. Among authors: potter de. Biomed Chromatogr. 2000 Apr;14(2):99-105. doi: 10.1002/(SICI)1099-0801(200004)14:2<99::AID-BMC933>3.0.CO;2-G. Biomed Chromatogr. 2000. PMID: 10694703

5

Beta-agonist-induced alterations in organ weights and protein content: comparison of racemic clenbuterol and its enantiomers.

von Deutsch DA, Abukhalaf IK, Wineski LE, Aboul-Enein HY, Pitts SA, Parks BA, Oster RA, Paulsen DF, Potter DE. von Deutsch DA, et al. Among authors: potter de. Chirality. 2000 Aug;12(8):637-48. doi: 10.1002/1520-636X(2000)12:8<637::AID-CHIR6>3.0.CO;2-W. Chirality. 2000. PMID: 10897101

6

Distribution and muscle-sparing effects of clenbuterol in hindlimb-suspended rats.

von Deutsch DA, Abukhalaf IK, Wineski LE, Roper RR, Aboul-Enein HY, Paulsen DF, Potter DE. von Deutsch DA, et al. Among authors: potter de. Pharmacology. 2002 May;65(1):38-48. doi: 10.1159/000056184. Pharmacology. 2002. PMID: 11901300

7

Rilmenidine-induced ocular hypotension: role of imidazoline1 and alpha 2 receptors.

Chu TC, Wong W, Gluchowski C, Hughes BW, Potter DE. Chu TC, et al. Among authors: potter de. Curr Eye Res. 1996 Sep;15(9):943-50. doi: 10.3109/02713689609017639. Curr Eye Res. 1996. PMID: 8921215

8

Comparative effects of alpha-2 and DA-2 agonists on intraocular pressure in pigmented and nonpigmented rabbits.

Ogidigben MJ, Potter DE. Ogidigben MJ, et al. Among authors: potter de. J Ocul Pharmacol. 1993 Fall;9(3):187-99. doi: 10.1089/jop.1993.9.187. J Ocul Pharmacol. 1993. PMID: 7901309

9

Oxymetazoline: potential mechanisms of inhibitory effects on aqueous humor dynamics.

Chu TC, Ogidigben MJ, Potter DE. Chu TC, et al. Among authors: potter de. Pharmacology. 1996 Oct;53(4):259-70. doi: 10.1159/000139438. Pharmacology. 1996. PMID: 8958565

10

Modulation of ocular hydrodynamics and iris function by bremazocine, a kappa opioid receptor agonist.

Russell KR, Wang DR, Potter DE. Russell KR, et al. Among authors: potter de. Exp Eye Res. 2000 May;70(5):675-82. doi: 10.1006/exer.2000.0832. Exp Eye Res. 2000. PMID: 10870526

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

152 results

Search Page

Filters